KLRK1 and adenocarcinoma: Furthermore, Guerra et al. using a genetic approach showed that NKG2D-deficient transgenic adenocarcinoma of the mouse prostate (TRAMP) developed three times more aggressive tumors than NKG2D-intact TRAMP littermates (65).